Body weight and mortality among adults who never smoked

American Journal of Epidemiology

Volumn 150, Issue 11, 1999, Pages 1152-1164

  Singh, Pramil N ^a   Lindsted, Kristian D ^a   Fraser, Gary E ^a  

^a LOMA LINDA UNIVERSITY   (United States)

Author keywords

Body weight; Estradiol; Menopause; Mortality; Obesity; Smoking

Indexed keywords

ESTRADIOL; ESTROGEN;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BODY WEIGHT; CIGARETTE SMOKING; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; MORTALITY; OBESITY; POSTMENOPAUSE; RISK FACTOR;

EID: 0033485603     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009942     Document Type: Article

References (62)

1. Van Italie T. Health implications of overweight and obesity in the United States. Ann Intern Med 1985;103:983-8.
2. Pi-Sunyer FX. Health implications of obesity. Am J Clin Nutr 1992;53:1595S-1603S.
3. Dietary guidelines for Americans. Washington, DC: US GPO, 1990. (Publication no. 1990-261-463/20444).
4. Dietary guidelines for Americans. Washington, DC: US GPO, 1996. (Publication no. 1996-402-519).
5. Manson JE, Stampfer MJ, Hennekens CH, et al. Body weight and longevity: a reassessment. JAMA 1987;257:353-8.
6. Sidney S, Friedman G, Siegelaub A. Thinness and mortality. Am J Public Health 1987;77:317-22.
7. Lee I-M, Manson JE, Hennekens CH, et al. Body weight and mortality: a 27 year follow-up of middle aged men. JAMA 1993;270:2823-8.
8. Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med 1995;333:677-85.
9. Seidell JC, Verschuren WMM, van Leer EM, et al. Overweight, underweight, and mortality. Arch Intern Med 1996;156: 958-63.
10. Lindsted KD, Singh PN. Body mass and 26-year risk of mortality among men who never smoked: a re-analysis among men of the Adventist Mortality Study. Int J Obesity 1998;22:544-8.
11. Harris TB, Cook EF, Garrison R, et al. Body mass index and mortality among non-smoking older persons: the Framingham Study. JAMA 1988;259:1520-4.
12. Rissanen A, Knekt P, Heliovaara M, et al. Weight and mortality in Finnish Women. J Clin Epidemiol 1991;44:787-95.
13. Cornoni-Huntley JC, Harris TB, Everett DF, et al. An Overview of body weight of older persons, including the impact on mortality. J Clin Epidemiol 1991;44:743-53.
14. Sorkin JD, Zonderman AB, Costas PT Jr, et al. Twenty year follow-up of the NHANES I cohort: test of methodologic hypotheses. (Abstract). Obes Res 1996;4(Supp 1):12s.
15. Lindsted KD, Singh PN. Body mass and 26-year risk of mortality among women who never smoked: Findings from the Adventist Mortality Study. Am J Epidemiol 1997;146:1-7.
16. Stevens J, Cai J, Pamuk ER, et al. The effect of age on the association between body-mass index and mortality. N Engl J Med 1998;338:1-7.
17. Tremollieres FA, Pouilles JM, Ribot C. Vertebral postmenopausal bone loss is reduced in overweight women: a longitudinal study in 155 early postmenopausal women. J Clin Endocrinol Metab 1993;77:683-6.
18. Dorgan JF, Reichman ME, Judd JT, et al. The relation of body size to plasma levels of estrogens and androgens in premenopausal women (Maryland, United States). Cancer Causes Control 1995;6(1)3-8.
19. Siiteri PK. Adipose tissue as a source of hormones. Am J Clin Nutr 1987;45:277-82.
20. Beeson WL, Mills PK, Phillips RL, et al. Chronic disease among Seventh-day Adventists, a low risk group. Cancer 1989;64:557-81.
21. Kuzma JW, Beeson WL. The relationship of lifestyle characteristics to mortality among California Seventh-day Adventists. In: Proceedings of the 18th National Meeting of the Public Health Conference on Records and Statistics. Hyattsville, MD: National Center for Health Statistics, US DHHS, 1981:195-200. (DHHS Publication no. (PHS) 81-2114).
22. Suzman RM, Harris T, Hadley EC, et al. In: Suzman RM, Willis DP, Manton KG, eds. The oldest old. New York: Oxford University Press, 1992:341-58.
23. Lemon FR, Walden RT, Woods RW. Cancer of the lung and mouth in Seventh-day Adventists. Cancer 1964;17:486-97.
24. Lemon FR, Walden RT. Death from respiratory system disease among Seventh-day Adventist men. JAMA 1966;198:117-26.
25. Calkins BM, Whittaker DJ, Rider AA, et al. Diet, nutrition, and metabolism in populations at and low risk for colon cancer. Population: demographic and anthropometric characteristics. Am J Clin Nutr 1984;40:887-95.
26. Fraser GE, Sabate J, Beeson WLB, et al. A possible protective effect of nut consumption on risk of coronary heart disease. The Adventist Health Study. Arch Intern Med 1992;152: 1416-24.
27. Fraser GE, Beeson WL. A comparison of stepwise correlational and stepwise regression methods of constructing nutrient indices. (Abstract). Am J Clin Nutr 1997;65(suppl):1333S.
28. Beaton GH, Milner J, Corey P, et al. Sources of variance in 24-hour recall data: implications for nutrition study design and interpretation. Am J Clin Nutr 1979;32:2546-59.
29. Willett WC. Nutritional epidemiology. New York: Oxford University Press, 1989.
30. Fraser GE, Strahan M, Sabate J, et al. Effects of traditional coronary risk factors on rates of incident coronary events in low-risk population. Circulation 1992;86:406-13.
31. Fraser GE, Shavlik D. Risk factors, lifetime risk, and age at onset of breast cancer. Ann Epidemiol 1997;7:375-82.
32. Fraser GE, Shavlik DJ. Risk factors for all-cause and coronary heart disease mortality in the oldest-old: the Adventist Health Study. Arch Intern Med 1997;157:2249-58.
33. Singh PN, Tonstad S, Abbey DE, et al. Validity of selected physical activity questions in white Seventh-day Adventists and non-Adventists. Med Sci Sport Exerc 1996;28:1026-37.
34. Cupples LA, Gagnon DR, Ramaswamy R, et al. Age-adjusted survival curves with application in the Framingham Study. Stat Med 1995;14:1731-44.
35. Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology 1995; 6:356-65.
36. National Institutes of Health Consensus Development Panel on the Health Implications of Obesity. Health implications of obesity. Ann Intern Med 1985;103:1073-7.
37. Garrison RJ, Feinleib M, Castelli WP, et al. Cigarette smoking as a confounder of the relationship between relative weight and long term mortality. JAMA 1983;249:2199-2203.
38. Stamler R, Ford CE, Stamler J. Why do lean hypertensives have higher mortality rates than other hypertensives? Findings of the Hypertension and Detection Follow-up Program. Hypertension 1991;17:553-64.
39. Tayback M, Kumanyika S, Chee E. Body weight as a risk factor in the elderly. Arch Intern Med 1990;150:1065-72.
40. Rumpel C, Harris TB, Madans J. Modification of the relationship between Quetelet index and mortality by weight loss history among older women. Ann Epidemiol 1993;3:343-50.
41. Losonczy KG, Harris TB, Cornoni-Huntley J, et al. Does weight loss from middle age to old age explain the inverse weight mortality relation in old age? Am J Epidemiol 1995; 141:312-21.
42. Mills PK, Beeson WL, Phillips RL, et al. Prospective study of exogenous hormone use and breast cancer in Seventh-day Adventists. Cancer 1989;64:591-7.
43. Kiani F, Knutsen S. Estrogen replacement therapy and the risk of myocardial infarction: the Adventist Health Study. (Abstract). Am J Epidemiol 1996;143(Suppl):S69.
44. Sowers MR, La Pietra MT. Menopause: its epidemiology and potential association with chronic diseases. Epidemiol Rev 1995;17:287-301.
45. Lieberman D, Kopernic G, Porath A, et al. Influence of estrogen replacement therapy on airway reactivity. Respiration 1995;62:205-8.
46. Juniper EF, Daniel EE, Roberts RS, et al. Improvement in airway responsiveness and asthma severity during pregnancy. A prospective study. Am Rev Respir Dis 1989;140:924-31.
47. Skobeloff EM, Spivey WH, Silverman R, et al. The effect of the menstrual cycle on asthma presentation in the emergency department. Arch Intern Med 1996;156:1837-40.
48. Pickett CK, Regensteiner JG, Woodard WD, et al. Progestin and estrogen reduce sleep-disordered breathing in postmenopausal women. J Appl Phys 1989;66:1656-61.
49. Thomas HV, Reeves GK, Key TJA. Endogenous estrogen and postmenopausal breast cancer: a quantitative review. Cancer Causes Control 1997;8:922-8.
50. Farhat MY, Abi-Younes S, Dingaan B, et al. Estradiol increases cyclic adenosine monophosphate in rat pulmonary vascular smooth muscle cells by a nongenomic mechanism. JPET 1996;276:652-7.
51. Massaro GD, Mortola JP, Massaro D. Estrogen modulates the dimensions of the lung's gas-exchange surface area and alveoli in female rats. Am J Physiol 1996;270:110-14.
52. Lacort M, Leal AM, Liza M, et al. Protective effect of estrogens and catecholestrogens against peroxidative membrane damage in vitro. Lipids 1995;30:141-6.
53. Thomas HV, Reeves GK, Key TJA. Endogenous estrogen and postmenopausal breast cancer: a quantitative review. Cancer Causes Control 1997;8:922-8.
54. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108 411 women without breast cancer. Lancet 1997;350:1047-59.
55. Ballard-Barbash R, Swanson CA. Body weight: estimation of risk for breast and endometrial cancers. Am J Clin Nutr 1996;63(suppl):437S-441S.
56. Barrett-Connor E. Postmenopausal estrogen and prevention bias. Ann Intern Med 1991;115:455-6.
57. Matthews KA, Kuller LH, Wing RR, et al. Prior to use of estrogen replacement therapy, are users healthier than non-users? Am J Epidemiol 1996;143:971-8.
58. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605-13.
59. Petitti DB. Hormone replacement therapy and heart disease prevention: experimentation trumps observation. JAMA 1998;280:650-2.
60. Dorn JM, Schisterman EF, Winkelstein W, et al. Body mass index and mortality in a general population sample of men and women. Am J Epidemiol 1997;146:919-31.
61. Durazo-Arvizu R, McGee DL, Cooper RS, et al. Mortality and optimal body mass index in a sample of the US population. Am J Epidemiol 1998;147:739-49.
62. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Washington, DC: US GPO, 1998. (NHLBI Preprint, June 1998).